http://www.nzherald.co.nz/trade-deal...ectid=11629084
Relatively optimistic article however a few points to consider re. potential headwinds.
1. "
UBS estimates 70 per cent of A2's formula sales in Australia and New Zealand actually end up in the Asian grey trade, predominantly China."
2. "Research shows reputation more important than country of origin.
Good to see the mention of the results from the 'clinical trial' last week although claiming lactose intolerance based on a 45 participant trial is hardly statistically significant. Promising nevertheless.